Ken Griffin Berkeley Lights, Inc. Transaction History

Citadel Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.04 - $2.77 $14,525 - $38,688	-13,967 Reduced 17.23%	67,104 $77,000
Q4 2022 Feb 14, 2023	SELL	$1.9 - $3.58 $314,271 - $592,153	-165,406 Reduced 67.11%	81,071 $217,000
Q3 2022 Nov 14, 2022	BUY	$2.86 - $5.78 $564,343 - $1.14 Million	197,323 Added 401.44%	246,477 $705,000
Q2 2022 Aug 15, 2022	SELL	$3.77 - $7.34 $333,094 - $648,518	-88,354 Reduced 64.25%	49,154 $244,000
Q1 2022 May 16, 2022	SELL	$5.12 - $19.26 $1.4 Million - $5.28 Million	-274,234 Reduced 66.6%	137,508 $978,000
Q4 2021 Feb 14, 2022	SELL	$17.39 - $25.74 $781,089 - $1.16 Million	-44,916 Reduced 9.84%	411,742 $7.49 Million
Q3 2021 Nov 15, 2021	BUY	$19.5 - $50.03 $7.94 Million - $20.4 Million	407,151 Added 822.41%	456,658 $8.93 Million
Q2 2021 Aug 16, 2021	SELL	$36.4 - $52.99 $6.92 Million - $10.1 Million	-190,155 Reduced 79.34%	49,507 $2.22 Million
Q1 2021 May 17, 2021	BUY	$44.33 - $89.26 $10 Million - $20.2 Million	226,079 Added 1664.43%	239,662 $12 Million
Q4 2020 Feb 16, 2021	SELL	$70.38 - $106.0 $1.7 Million - $2.57 Million	-24,210 Reduced 64.06%	13,583 $1.21 Million
Q3 2020 Nov 16, 2020	BUY	$56.0 - $76.36 $2.12 Million - $2.89 Million	37,793 New	37,793 $2.89 Million

2.22M

Ticker BLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,283,904
Market Cap $55.3M
Description
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and applic...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.